What changed for Eating Disorders
A plain English summary of what recently moved in the public data Voxsanity tracks for Eating Disorders. Updated from government registries. Not medical advice.
How to read these changes: every figure on this page is the difference between two snapshots of what Voxsanity had tracked on each date. Voxsanity only began taking daily snapshots in July 2026 and is still ingesting the public registries, so a rise here is mostly our own coverage expanding rather than new research appearing. Read it as our tracked coverage growing, not as a claim about real-world research changing this fast: it overstates how much actually changed.
Comparing the two most recent snapshots, 27 July 2026 and 28 July 2026.
- Trials on record 734 to 736 (+2)
Newly subsidised on the PBS
No PBS-reviewed medicines are tracked for Eating Disorders yet, so new PBS listings cannot be reported for it. This is a gap in what Voxsanity has mapped, not a statement that no medicines are subsidised — check the PBS directly.
Past updates
Tracking began in July 2026. Month on month changes will appear here once a second month of data has been recorded. Until then, the comparison above shows the most recent movement.
Recent trend
Weekly, most recent weeks (fills out to a monthly trend as history grows).
Recent trial results
The 30 most recent of 44 trials tracked for Eating Disorders that have reported results to a public registry.
AI generated results summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
-
NCT04038190 · results posted 28 May 2026
According to the results reported on ClinicalTrials.gov, this trial enrolled 572 university students — 287 in a programme called Behavioural Activation (BA) and 285 in a standard orientation control group (SO). The trial was measuring alcohol use and related problems, as well as depression and binge eating, across several points in time: at the start, mid-semester, end of semester, five months later, and (for some participants) seventeen months later. Completion rates were high early on but dropped notably at the later follow-up points, with around 155–206 participants completing the five-mont...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT05499676 · results posted 5 May 2026
According to the results reported on ClinicalTrials.gov, this trial enrolled 90 people in total — 30 in each of three groups. One group received treatment as usual (meaning they were referred to standard care), one group used a mobile app with coaching support, and a third group used the same mobile app with coaching support plus a social networking feature. The trial tracked participants over roughly nine months, measuring things like eating disorder-related thoughts and behaviours, body mass index (BMI), depression, and how much daily life was being affected by eating disorder symptoms. The...
-
NCT05753410 · results posted 16 April 2026
According to the results reported on ClinicalTrials.gov, 32 people took part in a single-group trial of a program called "Mindful Courage," with 30 completing it and 2 not finishing. The trial was primarily measuring whether the program was feasible to complete and whether participants found it acceptable. It also tracked changes in eating disorder symptoms, difficulties managing emotions, body dissatisfaction, and beliefs around "savouring" — that is, the ability to appreciate and enjoy positive experiences. The reported data shows that, on average, participants completed 87.8% of the progra...
-
NCT04636840 · results posted 9 March 2026
According to the results reported on ClinicalTrials.gov, this trial involved 148 young people in total — 51 in a group that used a mobile app with a social networking feature (Group A), 48 in a group that used the mobile app alone (Group B), and 49 in a control group. The trial was measuring eating disorder thoughts and behaviours, quality of life, depression symptoms, anxiety symptoms, and time spent using the app, across four points in time: the start of the study, at six weeks, at three months, and at six months. The reported data shows that eating disorder symptom scores (measured on a sc...
-
NCT04409457 · results posted 14 January 2026
According to the results reported on ClinicalTrials.gov, this trial involved two main groups: 51 people with bulimia nervosa and 49 people without the condition (healthy controls) who went through an initial screening phase. After screening, those who were eligible were randomly assigned to complete two brain-scanning sessions — one after fasting and one after eating a meal — in different orders. In total, 33 participants with bulimia nervosa and 35 healthy controls completed the screening, and around 16–17 people per group went on to complete the randomised scanning sessions. The trial was me...
-
NCT03946111 · results posted 17 December 2025
According to the results reported on ClinicalTrials.gov, this trial (NCT03946111) enrolled a very small number of participants — 1 person in the naltrexone/bupropion (combination medication) group and 2 people in the placebo (inactive treatment) group, and all 3 completed the study. The trial was measuring two main things: how often binge-eating episodes occurred over a 28-day period, and changes in body weight over time. Because of the very small number of participants, the reported numbers should be read with that context in mind. The reported data shows that, for binge-eating frequency (me...
-
NCT04428580 · results posted 29 August 2025
According to the results reported on ClinicalTrials.gov, this trial involved 123 therapists or clinicians who were split into two groups: 61 received online training and 62 received webinar-based training. The trial was not testing a medical treatment — instead, it was looking at two different ways of training practitioners in a therapy approach, and measuring whether it was practical to run a larger study in the future. The key things being tracked were whether enough people could be recruited and whether they would stay involved through to the end of training. The reported data shows that r...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT05389657 · results posted 7 August 2025
According to the results reported on ClinicalTrials.gov, this trial involved 85 participants in total — 56 in an online training group and 29 in a live (in-person) training group. The trial was testing two different ways of training healthcare providers in a type of treatment called Family-Based Treatment (FBT), which is used for eating disorders. The trial measured how many providers completed the training, how much knowledge they gained about FBT, and whether they went on to receive follow-up consultation support in the 12 months after training. The reported data shows that, of the 56 peopl...
-
NCT04128683 · results posted 11 April 2025
According to the results reported on ClinicalTrials.gov, this trial involved 13 people in total — 7 healthy volunteers and 6 people diagnosed with anorexia nervosa. The trial was examining how the brain responds to unexpected rewards (in this case, taste experiences like a sweet drink) and to anticipating those taste experiences. To do this, researchers used brain scans (MRI) while participants completed a taste-based task. Each person took part in three separate scan sessions, and before each session they received one of three things: a drug called amisulpride (which affects a brain chemical...
-
NCT05806788 · results posted 7 January 2025
According to the results reported on ClinicalTrials.gov, this trial (NCT05806788) tested a behavioural program called the BESTOW Behavioral Intervention, which was designed to address binge eating. Twenty people enrolled in the study, 17 completed it, and 3 did not finish. The trial was primarily looking at whether the program was practical and acceptable to participants — in other words, whether people found it easy enough to use and felt it was a reasonable way to address their binge eating. It also tracked self-reported binge eating symptoms and depressive symptoms over time as secondary me...
-
NCT04088097 · results posted 10 October 2024
According to the results reported on ClinicalTrials.gov, this trial involved 50 people in total — 25 in a Cognitive-Behavioural Therapy (CBT) group and 25 in a control (comparison) group. The trial was measuring two main things: how often participants experienced episodes of binge eating (described as loss-of-control eating), and any changes in their body weight, measured as a percentage change in BMI (Body Mass Index — a standard number calculated from a person's height and weight). By the end of the study, 23 people in the CBT group and 21 in the control group had completed the trial, with 2...
-
NCT04771455 · results posted 19 September 2024
According to the results reported on ClinicalTrials.gov, this trial (NCT04771455) enrolled 81 participants across eight groups of roughly 10–11 people each. Of those, 73 completed the study — between 8 and 11 people finished in each group depending on the group. The trial was looking at two main things: changes in body weight (measured in pounds) and changes in the number of binge eating episodes over a 28-day period. Participants were divided according to three characteristics: whether they placed a high importance on their weight or body shape, whether they used unhealthy weight control prac...
-
NCT02977403 · results posted 20 August 2024
According to the results reported on ClinicalTrials.gov, this trial involved 68 people in total — 36 in a control group and 32 in a retraining group. The study was looking at whether a type of computer-based attention training (called "attention bias retraining") could change the way people's attention is drawn toward images of appealing food. It measured two things: how quickly people reacted to food-related images in a visual task (using reaction times in milliseconds), and changes in a type of brain activity called "beta band oscillatory power" — essentially a measure of electrical signal p...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT03449095 · results posted 31 July 2024
According to the results reported on ClinicalTrials.gov, this trial involved 640 people in total — 320 who were given an alcoholic drink and 320 who were given a non-alcoholic control drink. All 640 participants completed the study with no dropouts recorded. The trial was measuring how drinking alcohol in a group setting affected people's mood and sense of social closeness, using self-reported questionnaires completed during a laboratory session. The reported data shows that for the mood measure (scored from 1 to 6), the alcohol group scored 3.49 on positive emotion and 0.32 on negative emoti...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT03712462 · results posted 26 April 2024
According to the results reported on ClinicalTrials.gov, this trial involved 126 people in total — 63 in each of two groups. One group received a treatment called ABBT Weight Loss Therapy (a mindfulness- and acceptance-based approach combined with weight loss support), and the other received Standard Behavior Therapy. Both groups were being studied for changes in weight and eating-related thoughts and behaviours over two years. Of the 126 who started, 43 in each group completed the study, meaning 20 people in each group did not finish. The reported data shows that both groups lost a similar p...
-
NCT02887586 · results posted 30 January 2024
According to the results reported on ClinicalTrials.gov, this trial enrolled 60 people in total — 30 in an "auricular needling" group (a form of acupuncture applied to points on the ear) and 30 in a control group. The trial was looking at appetite and related measures in cancer patients. By the end of the study, 27 people in the needling group and 28 in the control group had completed the trial, with a small number dropping out from each group. The reported data shows that two questionnaires were used as the main measures of appetite. The first, called the Simplified Nutritional Appetite Ques...
-
NCT04935931 · results posted 21 August 2023
According to the results reported on ClinicalTrials.gov, this trial enrolled 13 participants in a single-group study, with 12 completing it and 1 not completing it. The study was investigating how a single dose of a medicine called naltrexone affected brain activity — specifically in two regions of the brain linked to reward and decision-making — using a type of brain scan called an MRI (which measures changes in blood flow as a sign of brain activity). The reported data shows that after taking a single dose of naltrexone, brain activity in an area called the nucleus accumbens (a region invol...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT03539900 · results posted 24 July 2023
According to the results reported on ClinicalTrials.gov, this trial involved 89 participants in total — 43 in the group receiving a medication called NB (naltrexone-bupropion) and 46 in a placebo group (a dummy treatment with no active ingredient). Most participants completed the trial: 38 from the medication group and 44 from the placebo group. The trial was measuring two main things: how often participants experienced binge-eating episodes per month, and changes in their Body Mass Index (BMI — a number calculated from height and weight) over the course of treatment. The reported data shows...
-
NCT03604172 · results posted 18 April 2023
According to the results reported on ClinicalTrials.gov, this trial (NCT03604172) enrolled 40 people in total — 20 in a Cognitive Behavioural Therapy (CBT) group and 20 in a waitlist control group (people who waited rather than receiving the therapy straight away). Of those, 19 in the CBT group and 18 in the waitlist group completed the study. The trial was measuring brain activity and self-reported eating behaviours, with a particular focus on how the brain responded to high-calorie food images and descriptions of binge-eating episodes, as well as changes in binge-eating frequency and eating-...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT03784820 · results posted 11 April 2023
According to the results reported on ClinicalTrials.gov, this trial compared two therapy approaches for binge eating disorder: CBT-E (a form of cognitive behavioural therapy delivered to patients alone) and UNITE (a therapy that involved both patients and their partners). Each group started with 11 patients and 11 partners, giving 44 participants in total. The trial tracked people at several points: before treatment started, during treatment, at the end of treatment, and then at 3 months and 6 months after treatment finished. The main thing being measured was how many patients stopped binge ea...
-
NCT04753164 · results posted 31 March 2023
According to the results reported on ClinicalTrials.gov, this trial (NCT04753164) involved 136 people in total — 68 who received a medication called ACT-539313 (taken as a 100 mg dose twice a day) and 68 who received a placebo (a dummy treatment with no active ingredient). The trial ran for 12 weeks and was primarily measuring changes in the number of days per week on which participants experienced binge eating episodes. Not everyone finished the trial: 41 out of 68 participants in the ACT-539313 group completed the study, compared with 48 out of 68 in the placebo group. The reported data sho...
-
NCT03045341 · results posted 20 December 2022
According to the results reported on ClinicalTrials.gov, this trial enrolled 136 people across four groups: one group received a placebo (an inactive pill), one received a medication called NB (naltrexone-bupropion), one received a behavioural weight loss programme (BWL) plus placebo, and one received the behavioural weight loss programme plus the NB medication. The trial was measuring two main things: how often participants had binge-eating episodes each month, and whether their body weight changed over the course of the study. By the end of the trial, between 27 and 29 people in each group h...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT04278755 · results posted 26 July 2022
According to the results reported on ClinicalTrials.gov, this trial (NCT04278755) enrolled 8 participants in a single group, all of whom were taking a continuous oral contraceptive (OC). Seven participants completed the study and one did not finish. The trial was measuring several things before and after the intervention: how often participants experienced binge eating episodes per week, their score on a binge eating questionnaire, activity in specific brain regions (the nucleus accumbens, dorsal striatum, and prefrontal cortex) in response to reward cues during a brain scan task, and a measur...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT04957498 · results posted 13 December 2021
According to the results reported on ClinicalTrials.gov, this trial (NCT04957498) enrolled 40 people across two groups of 20 each. One group received a treatment called FBT-V (family-based therapy delivered via video) and the other received GSH-FBT (a guided self-help version of family-based therapy). The trial was a feasibility study — meaning it was designed not to test whether a treatment works, but to measure whether it was practical to run a larger trial in future. It looked at things like how easily people could be recruited, how many stayed in the study, and how acceptable participants...
-
NCT02805972 · results posted 3 November 2021
According to the results reported on ClinicalTrials.gov, this trial (NCT02805972) involved 41 people in total across two groups. It used a "crossover" design, meaning each person received both naloxone and a placebo (a dummy treatment) at separate visits, with a washout period in between. The trial was measuring whether people reported feeling nauseous after receiving naloxone compared to after receiving the placebo, and also looked at a stress hormone in saliva (cortisol) and scores on a withdrawal symptom questionnaire. The reported data shows that, for the main outcome at 10 minutes after...
-
NCT03652675 · results posted 20 July 2021
According to the results reported on ClinicalTrials.gov, this trial (NCT03652675) enrolled 31 people in total — 16 in the intervention group, who received a programme called HealthCall for HIV/HCV alongside a clinician's guide, and 15 in an educational control group. By the end of the study, 12 people in the intervention group and 11 in the control group had completed the trial, with 4 people leaving each group before the end. The trial was measuring alcohol drinking patterns — specifically how many drinks people had on days they drank, how many days they drank in a month, and the largest numb...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT01301183 · results posted 13 July 2021
According to the results reported on ClinicalTrials.gov, this trial enrolled 75 people in total — 38 in a group receiving a treatment called Rh IGF-1 combined with a skin-patch form of oestrogen, and 37 in a group receiving a placebo (an inactive substance) combined with the same oestrogen patch. The trial ran over 12 months and was primarily measuring changes in bone density in the lower spine, using a scoring system that shows how a person's bone density compares to the average for their age, sex, and racial group. A higher score over time was considered a more favourable result. The report...
-
NCT02488109 · results posted 24 June 2021
According to the results reported on ClinicalTrials.gov, this trial involved 116 young people (adolescents) who were hospitalised and being treated for an eating disorder. They were split into two groups: 60 received a Higher Calorie Refeeding (HCR) approach and 56 were assigned to a Lower Calorie Refeeding (LCR) approach (though 5 in the LCR group did not go on to receive treatment, leaving 51 in that group). The trial was measuring whether participants reached "clinical remission" — defined as both reaching a healthy weight for their age and sex, and scoring within a normal range on a psycho...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT02684279 · results posted 12 August 2020
According to the results reported on ClinicalTrials.gov, this trial enrolled 528 people who were all given a medicine called dasotraline. There was no comparison (placebo) group. The trial was a long-term safety study, and one of its main focuses was monitoring participants for any thoughts of suicide or self-harm, using a standardised questionnaire called the Columbia-Suicide Severity Rating Scale (C-SSRS). This scale rates the seriousness of suicidal thoughts from 0 (no thoughts at all) up to 5 (active thoughts with a plan and intention to act). Of the 528 people who started, 249 completed t...
-
NCT00762710 · results posted 4 June 2020
According to the results reported on ClinicalTrials.gov, this trial looked at alcohol consumption in people who were drinking heavily. A total of 92 participants took part — 48 received a medication called prazosin and 44 received a placebo (a dummy pill with no active ingredient). By the end of the study, 27 people in the prazosin group and 29 in the placebo group had completed the trial, meaning a notable number of participants did not finish in both groups. The main thing the trial measured was the percentage of days on which participants drank heavily, assessed over a 90-day period at the...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
See all 44 reported results for Eating Disorders
These are the results as reported to the registry, not medical advice. Verify independently with the trial site and discuss what they mean for you with your doctor.
What is coming
AI generated pipeline summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
According to NIH funding data, a moderate amount of public research funding is currently directed toward eating disorders, which suggests the condition is recognised within the broader research landscape. However, the direction of that funding has been falling year on year, which may mean fewer new studies are being initiated at the public level than in previous periods. For patients, this trend i...
See the full Eating Disorders page
Not medical advice. Voxsanity republishes public government health data in plain English. These figures describe research and registry activity, not the suitability of any treatment for any person. Trial status can change; always verify current status directly with the trial site and confirm Australian availability with your doctor.